Nagaland University researchers have identified Sinapic acid, a natural plant compound, as a potential breakthrough for treating diabetic wounds. This ...

Cidara’s lead candidate, CD388, is a long-acting antiviral prophylactic designed for universal prevention of seasonal and ...

PranaX Corporation, a leading biotechnology company specializing in regenerative biologics, has announced that a study concerning the exosome manufacturing technology exclusively licensed for ...

US states are currently enrolling patients in BriaCell’s pivotal Phase 3 study in metastatic breast cancer (MBC) Dartmouth Cancer Center, Cedars-Sinai Medical Center, and Winship Cancer Institute of ...

During the COVID-19 pandemic, AI-assisted sequencing pipelines were instrumental in tracking SARS-CoV-2 variants, ...

“Our work is the first to directly test how chromosome structure affects bacterial growth, survival, and ability to cause ...

Researchers from the University of East Anglia and biotechnology company Oxford Biodynamics have developed a new blood test ...

Researchers analyzed 11 trials with 655 adults and discovered that taking vitamin D2 supplements decreases the body's vitamin ...

A common vegetable has been found to reduce blood pressure in older people, a new study suggests. Beetroot juice can lower ...

Kerala’s bioeconomy sector has witnessed a considerable annual growth rate of 12% as per the Kerala Bioeconomy Report 2025, prepared by the Association of Biotechnology Led Enterprises (ABLE).

A new study led by researchers from the University of Tasmania, in collaboration with international partners including The ...

Dose expansion phase will determine the recommended Phase 2 dose of R289 for patients with transfusion dependent R/R lower-risk MDS SOUTH SAN FRANCISCO, Calif.